Divisadero Street Capital Management LP Makes New $7.48 Million Investment in Nutex Health Inc. $NUTX

Divisadero Street Capital Management LP bought a new stake in Nutex Health Inc. (NASDAQ:NUTX) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 60,094 shares of the company’s stock, valued at approximately $7,481,000. Divisadero Street Capital Management LP owned 1.08% of Nutex Health at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the company. Ameritas Investment Partners Inc. purchased a new stake in Nutex Health in the 2nd quarter worth about $44,000. Bank of America Corp DE boosted its position in Nutex Health by 6,590.3% during the fourth quarter. Bank of America Corp DE now owns 2,074 shares of the company’s stock worth $66,000 after purchasing an additional 2,043 shares during the period. Police & Firemen s Retirement System of New Jersey bought a new position in Nutex Health during the second quarter worth about $97,000. KLP Kapitalforvaltning AS purchased a new position in shares of Nutex Health in the second quarter worth about $112,000. Finally, New York State Common Retirement Fund bought a new stake in shares of Nutex Health in the second quarter valued at approximately $137,000. Hedge funds and other institutional investors own 5.32% of the company’s stock.

Insider Buying and Selling

In other Nutex Health news, CFO Jon Christian Bates bought 750 shares of the firm’s stock in a transaction on Tuesday, November 25th. The shares were acquired at an average cost of $136.71 per share, for a total transaction of $102,532.50. Following the purchase, the chief financial officer directly owned 5,638 shares of the company’s stock, valued at $770,770.98. The trade was a 15.34% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 36.92% of the stock is currently owned by insiders.

Nutex Health Stock Performance

Nutex Health stock opened at $160.95 on Monday. Nutex Health Inc. has a 1-year low of $28.12 and a 1-year high of $184.27. The company has a current ratio of 3.20, a quick ratio of 3.18 and a debt-to-equity ratio of 0.67. The firm has a market capitalization of $1.14 billion, a PE ratio of 8.70 and a beta of -0.03. The firm’s 50 day simple moving average is $116.89 and its 200 day simple moving average is $111.83.

Nutex Health (NASDAQ:NUTX) last released its quarterly earnings results on Tuesday, November 18th. The company reported $7.76 EPS for the quarter, beating analysts’ consensus estimates of ($5.43) by $13.19. The firm had revenue of $243.99 million during the quarter, compared to analyst estimates of $221.93 million. Nutex Health had a net margin of 11.62% and a return on equity of 37.44%.

Analyst Upgrades and Downgrades

NUTX has been the subject of several analyst reports. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Nutex Health in a report on Monday, December 1st. Maxim Group set a $205.00 target price on Nutex Health and gave the stock a “buy” rating in a research report on Tuesday, August 26th. Finally, Wall Street Zen raised Nutex Health from a “buy” rating to a “strong-buy” rating in a report on Friday, November 28th. Two research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, Nutex Health has a consensus rating of “Moderate Buy” and an average target price of $252.50.

About Nutex Health

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.